Blog Articles

View all posts 

ESG: non-surgical, endoscopic, 15-20% weight loss, low risk (1-2%), reversible, suits BMI 30-50. Gastric sleeve: surgical, 25-30% weight loss, higher risk (5-10%), irreversible, ideal for BMI >40. Choice depends on health, goals, and risk preference.

ESG, a non-surgical weight loss procedure, upto 18% TBWL at 1-2 yrs, up to 49% EWL (MERIT trial), with low risks (1-5%). Effective across obesity classes, it outperforms Semaglutide in cost and durability, improving comorbidities. Ideal for BMI 30-50.

ESG: minimally invasive, endoscopic, 15-20% weight loss, low risk (1-2%), reversible, suits BMI 30-50. Gastric bypass: surgical, 25-35% weight loss, higher risk (5-10%), permanent, ideal for BMI >40. Choice depends on health, goals, risk tolerance.

ESG: non-surgical, endoscopic, 15-20% weight loss, lasting results, suits BMI 30-50. Gastric balloon: temporary, 10-15% weight loss, lower cost, less durable, BMI - 30-40. ESG offers better long-term value; balloon suits short-term goals.

Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure reducing stomach size by 70-80% to aid weight loss. Ideal for BMI 30-50, it offers 15-20% weight loss, quick recovery, and fewer risks than surgery.

.

What Are Endoscopic Procedures for Weight Loss?

At Aliva Weight Loss, we use FDA-approved medications and personalized lifestyle changes to help you achieve and maintain significant weight loss. Our holistic approach includes continuous support and effective treatments like GLP-1 receptor agonists.